TIME-COURSE AND CYTOKINE DEPENDENCE OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-1 T-LYMPHOCYTE TRANSFORMATION AS REVEALED BY A MICROTITER INFECTIVITY ASSAY

被引:30
作者
PERSAUD, D
MUNOZ, JL
TARSIS, SL
PARKS, ES
PARKS, WP
机构
关键词
D O I
10.1128/JVI.69.10.6297-6303.1995
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human T-cell lymphotropic virus type 1 (HTLV-1) enhances the growth of T lymphocytes, allowing the generation of T-lymphocyte cell lines. This report describes a limiting-dilution assay system which uses low input numbers of HTLV-1-producing cells for generation of T-lymphocyte cultures. The HTLV-1 transformants generated with this assay system produced high levels of HTLV-1 p24 antigen and required exogenous cytokines for maintenance. Clonal populations of CD4- or CD8-positive HTLV-1 transformants were generated with transformation efficiency rates as high as 78%. An exogenous cytokine is necessary for HTLV-1 T-lymphocyte transformation, and cytokine dependence is the most likely outcome of infection and transformation. HTLV-1 T-lymphocyte transformation can occur in the presence of cytokines other than interleukin-2 (IL-2), such as IL-4 or IL-7. IL-4- or IL-7-dependent HTLV-1 transformants underwent T-lymphocyte mitogenesis in response to their homologous cytokines but proliferated best in the presence of IL-2. Since the receptors for IL-2, IL-4, and IL-7 share the IL-2 gamma chain, this component may be the common element in the signaling pathway for HTLV-1-associated transformation.
引用
收藏
页码:6297 / 6303
页数:7
相关论文
共 34 条
[1]  
BONNARD GD, 1979, J IMMUNOL, V123, P2704
[2]  
CANN AJ, 1990, VIROLOGY, P1501
[3]   TRANSIENT EXPRESSION OF INTERLEUKIN-2 RECEPTORS - CONSEQUENCES FOR T-CELL GROWTH [J].
CANTRELL, DA ;
SMITH, KA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (06) :1895-1911
[4]   HUMAN T-CELL LEUKEMIA-VIRUS TYPE-II TRANSFORMS NORMAL HUMAN-LYMPHOCYTES [J].
CHEN, ISY ;
QUAN, SG ;
GOLDE, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (22) :7006-7009
[5]   IMMORTALIZATION OF HUMAN LYMPHOCYTES-T BY HTLV-I - PHENOTYPIC CHARACTERISTICS OF TARGET-CELLS AND KINETICS OF VIRUS INTEGRATION AND EXPRESSION [J].
DELMISTRO, A ;
DEROSSI, A ;
ALDOVINI, A ;
SALMI, R ;
CHIECOBIANCHI, L .
LEUKEMIA RESEARCH, 1986, 10 (09) :1109-&
[6]   HUMAN T-CELL LEUKEMIA-VIRUS (HTLV-I) TRANSCRIPTS IN FRESH AND CULTURED-CELLS OF PATIENTS WITH ADULT T-CELL LEUKEMIA [J].
FRANCHINI, G ;
WONGSTAAL, F ;
GALLO, RC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (19) :6207-6211
[7]   12-O-TETRADECANOYLPHORBOL-13-ACETATE INDUCES THE ENHANCER FUNCTION OF HUMAN T-CELL LEUKEMIA-VIRUS TYPE-I [J].
FUJII, M ;
NAKAMURA, M ;
OHTANI, K ;
SUGAMURA, K ;
HINUMA, Y .
FEBS LETTERS, 1987, 223 (02) :299-303
[8]   HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUS TYPE-I (HTLV-I) EXPRESSION IN FRESH PERIPHERAL-BLOOD MONONUCLEAR-CELLS FROM PATIENTS WITH TROPICAL SPASTIC PARAPARESIS HTLV-I-ASSOCIATED MYELOPATHY [J].
GESSAIN, A ;
LOUIE, A ;
GOUT, O ;
GALLO, RC ;
FRANCHINI, G .
JOURNAL OF VIROLOGY, 1991, 65 (03) :1628-1633
[9]  
GESSAIN A, 1985, LANCET, V407, P122
[10]   UTILIZATION OF THE BETA-CHAIN AND GAMMA-CHAIN OF THE IL-2 RECEPTOR BY THE NOVEL CYTOKINE-IL-15 [J].
GIRI, JG ;
AHDIEH, M ;
EISENMAN, J ;
SHANEBECK, K ;
GRABSTEIN, K ;
KUMAKI, S ;
NAMEN, A ;
PARK, LS ;
COSMAN, D ;
ANDERSON, D .
EMBO JOURNAL, 1994, 13 (12) :2822-2830